In the US, Nolvadex (tamoxifen systemic) is a member of the following drug classes: hormones/antineoplastics, selective estrogen receptor modulators and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Male, Breast Cancer - Metastatic, Breast Cancer - Palliative, McCune-Albright Syndrome and Precocious Puberty.
Ingredient matches for Nolvadex
Tamoxifen is reported as an ingredient of Nolvadex in the following countries:
Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Nolvadex in the following countries:
- Bosnia & Herzegowina
- Costa Rica
- Croatia (Hrvatska)
- Czech Republic
- Dominican Republic
- El Salvador
- Hong Kong
- South Korea
- Trinidad & Tobago
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.